Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions

2000/01/01 by John H. Krystal, Alexandre Bennett, Danielle Abi-Saab +11 · 27 citations
Medicine · Neuroscience · #Treatment of Major Depression #Memory and Neural Mechanisms #Functional Brain Connectivity Studies

paper · doi:10.1016/s0006-3223(99)00097-9

Citations

• Recent advances in the phencyclidine model of schizophrenia

Cited by

• Ketamine-Induced Hallucinations
• Convergence of biological and psychological perspectives on cognitive coordination in schizophrenia
• Ketamine impairs multiple cognitive domains in rhesus monkeys. [europepmc]
• Subdissociative dose ketamine produces a deficit in manipulation but not maintenance of the contents of working memory. [europepmc]
• Early-stage visual processing and cortical amplification deficits in schizophrenia. [europepmc]
• Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex. [europepmc]
• Interaction of N-methyl-D-aspartate and group 5 metabotropic glutamate receptors on behavioral flexibility using a novel operant set-shift paradigm. [europepmc]
• Genetic variation in the DAOA gene complex: impact on susceptibility for schizophrenia and on cognitive performance. [europepmc]
• Longitudinal alterations of executive function in non-psychotic adolescents at familial risk for schizophrenia. [europepmc]
• N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? [europepmc]
• Disruption of performance in the five-choice serial reaction time task induced by administration of N-methyl-D-aspartate receptor antagonists: relevance to cognitive dysfunction in schizophrenia. [europepmc]
• Thinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical models. [europepmc]
• The effects of NMDA receptor antagonists on attentional set-shifting task performance in mice. [europepmc]
• Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits. [europepmc]
• Cognitive deficits following anti-NMDA receptor encephalitis. [europepmc]
• Stress-induced impairments in prefrontal-mediated behaviors and the role of the N-methyl-D-aspartate receptor. [europepmc]
• Effects of nicotine on the neurophysiological and behavioral effects of ketamine in humans. [europepmc]
• Glutamate-mediated excitotoxicity in schizophrenia: a review. [europepmc]
• Gamma rhythms link prefrontal interneuron dysfunction with cognitive inflexibility in Dlx5/6(+/-) mice. [europepmc]
• Advancing understanding of executive function impairments and psychopathology: bridging the gap between clinical and cognitive approaches. [europepmc]
• Ketamine-Induced Hallucinations. [europepmc]
• Role of N-Methyl-D-Aspartate Receptors in Action-Based Predictive Coding Deficits in Schizophrenia. [europepmc]
• Preclinical characterization of AMPA receptor potentiator TAK-137 as a therapeutic drug for schizophrenia. [europepmc]
• Neurobehavioural complications of sleep deprivation: Shedding light on the emerging role of neuroactive steroids. [europepmc]
• Anterior Cingulate Cortex Glutamate Levels Are Related to Response to Initial Antipsychotic Treatment in Drug-Naive First-Episode Schizophrenia Patients. [europepmc]
• A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics. [europepmc]
• The thalamus in psychosis spectrum disorder. [europepmc]